PACIFIC BIOSCIENCES OF CALIF (PACB)
US69404D1081 - Common Stock
| MRQ (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 76.65M | 631.42M | 325.10M | 460.70M | 81.60M | |||
| Marketable Securities | 485.27M | 451.50M | 447.20M | 583.70M | 237.20M | |||
| Receivables | 30.32M | 36.62M | 18.80M | 24.20M | 16.80M | |||
| Inventories | 67.34M | 56.68M | 50.40M | 24.60M | 14.20M | |||
| Other Current Assets | 17.44M | 17.34M | 10.60M | 7.90M | 5.70M | |||
| Total Current Assets | 677.02M | 742.05M | 852.10M | 1.10B | 355.60M | |||
| Non-Current Assets | ||||||||
| PPE Net | 67.96M | 69.03M | 81.30M | 79.10M | 54.90M | |||
| Goodwill | 462.26M | 462.26M | 410.00M | 410.00M | N/A | |||
| Intangibles | 450.13M | 456.98M | 410.20M | 411.00M | N/A | |||
| Other Non-Current Assets | 12.54M | 15.70M | 13.50M | 5.80M | 3.50M | |||
| Total Non-Current Assets | 992.90M | 1.00B | 915.00M | 905.90M | 58.40M | |||
| TOTAL ASSETS | 1.67B | 1.75B | 1.77B | 2.01B | 414.00M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 200.00K | 490.00K | 1.80M | N/A | 0.00 | |||
| Accrued Expenses | 31.76M | 55.30M | 41.50M | 44.00M | 21.70M | |||
| Accounts Payable | 21.01M | 15.06M | 12.00M | 11.00M | 3.60M | |||
| Other Current Liabilities | 19.98M | 24.18M | 208.00M | 16.70M | 13.20M | |||
| Total Current Liabilities | 72.95M | 95.03M | 263.30M | 71.70M | 38.50M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 892.75M | 892.74M | 897.20M | 896.10M | 0.00 | |||
| Other Non-Current Liabilities | 55.21M | 56.94M | 43.70M | 248.20M | 40.00M | |||
| Total Non-Current Liabilities | 947.95M | 949.68M | 940.90M | 1.14B | 40.00M | |||
| TOTAL LIABILITIES | 1.02B | 1.04B | 1.20B | 1.22B | 78.50M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -1.92B | -1.84B | -1.53B | -1.22B | -1.04B | |||
| Additional Paid In Capital | 2.57B | 2.54B | 2.10B | 2.01B | 1.37B | |||
| Common Shares | 272.00K | 268.00K | 200.00K | 200.00K | 200.00K | |||
| Other Shareholders' Equity | -306.00K | 219.00K | -4.80M | -1.10M | 100.00K | |||
| Shares Outstanding | 272.28M | 267.74M | 226.50M | 221.00M | 192.30M | |||
| Tangible Book Value per Share | -0.97 | -0.81 | -1.14 | -0.14 | 1.74 | |||
| Total Shareholders' Equity | 649.02M | 701.30M | 562.90M | 791.00M | 335.50M | |||
| TOTAL LIABILITIES AND EQUITY | 1.67B | 1.75B | 1.77B | 2.01B | 414.00M | |||
| Statistics | ||||||||
| Debt/Equity | 1.38 | 1.27 | 1.59 | 1.13 | N/A | |||
| Current Ratio | 9.28 | 7.81 | 3.24 | 15.36 | 9.24 | |||
| Return On Assets (ROA) | -17.78% | -17.57% | -17.78% | -9.03% | 7.10% | |||
| Return On Equity (ROE) | -45.75% | -43.74% | -55.82% | -22.91% | 8.76% | |||
All data in USD